Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion type Assertion NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_head.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion description "[The development of myelodysplastic syndrome/acute myeloblastic leukaemia (MDS/AML) has been reported in patients with aplastic anaemia (AA) after administration of recombinant human granulocyte colony-stimulating factor (rhG-CSF).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_provenance.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion evidence source_evidence_literature NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_provenance.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion SIO_000772 11122117 NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_provenance.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion wasDerivedFrom befree-2016 NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_provenance.
- NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_assertion wasGeneratedBy ECO_0000203 NP303459.RAIUx020xNVETikviMup3PIIai7eBrX-zVORJZQj3wUlw130_provenance.